AOD 9604 Dosage and Protocol: What the Research Supports The standard research protocol for AOD 9604 is 300 mcg per day, administered via subcutaneous injection
From a theoretical pharmacological standpoint, combining a peptide with putative lipolytic activity (AOD 9604) with a potent triple incretin receptor agonist (retatrutide) could potentially amplify metabolic effects but this is speculative and raises the possibility of compounding adverse effects with no safety data to guide dosing or monitoring
People with Digestive Issues : Individuals with Crohns disease, celiac sprue or individuals who have suffered mucosal injury through surgery or gastric banding surgery are unable to absorb vitamin B12
What Are the Most Common Side Effects After a B12 Shot
Do my hands or feet feel tingly
Benefits patients commonly report Supports the body's natural fat metabolism pathways Supports steady energy and reduces the drag of low B12 Often paired with weight management programs to complement diet and movement Supports liver function and healthy fat processing Quick weekly format that is easy to integrate into your routine A note on whole body wellness Healthier liver function, better metabolic balance, and improved energy show up in small visible ways, including clearer skin, more consistent sleep, and steadier mood across the week
